Analysts Are Betting On Keymed Biosciences Inc. (HKG:2162) With A Big Upgrade This Week

Simply Wall StNov 20 17:16 ET

Express News | KeyMed Biosciences Says Unit in Exclusive License Agreement for Platina Medicines to Make Bispecific Antibody Cm336

ReutersNov 17 05:17 ET

Keymed Biosciences Inc. (HKG:2162) Surges 11%; Retail Investors Who Own 37% Shares Profited Along With Institutions

Simply Wall StOct 22 19:38 ET

Bocom Intl: Rated 'Outperform' for Mainland pharmaceutical industry, focusing on innovative and consumer-driven symbol

The "Notice on Organizing Pharmaceutical Institutions to Submit the Demand Quantity of the Tenth Batch of National Centralized Procurement Drug Types" shows that the tenth batch of pharmaceutical national procurement includes a total of 263 specifications, involving 62 varieties, and plans to report quantities from October 18th to 28th, complete quantity review by each province before November 1st, and submit to the National Joint Procurement Office.

Zhitong FinanceOct 16 21:53 ET

BOCOM Intl: Short-term pharmaceutical sector still has some room for recovery, focusing on recommending Simcere Pharma (02096) and others.

bocom intl key recommended simcere pharma (02096), hutchmed (china) (00013), connoah-b (02162) and akeso (09926), etc.

Zhitong FinanceOct 9 22:19 ET

Bocom Intl: The fifth batch of consumables centralized procurement initiated, focusing on simcere pharma (02096) and other high-elastic symbols under the recovery of the sector.

Bocom Intl believes that there is still further room for recovery in the Mainland pharmaceutical sector in the short term.

Zhitong FinanceOct 2 22:36 ET